MedTrace Logo

Basic Care Revisited_Communication for Patient Participation

NCT02401919 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 175

Last updated 2015-03-30

No results posted yet for this study

Summary

COMMUNICATION - Feasibility and effectiveness 'Tell-us Cards' in hospital patients

* Objective - To investigate the feasibility and effectiveness of 'Tell-us Cards' on patient participation in basic care in hospital settings.
* Design - Cluster randomised controlled early trial design (Phase 2B, MRC Framework). Patients of two surgical and two medical wards (n=140) will be included in this study. Before and after the introduction of the intervention, assessments will take place in patients and nurses at these wards.
* Intervention - The 'Tell-us card' is a tool to elicit patients preferences and needs in basic care. Patients are invited to write down their specific questions and concerns. The cards are handed out to patients admitted to the hospital (daily). Patients and informal caregivers are invited to use the cards to state their preferences. Nurses are instructed to use the cards as a tool in their dialogue with the patient in making care plans, during ward rounds or for discharge information sessions.
* Comparison - Usual care
* Primary outcome - Patient perception of participation in care (Individualized Care Scale (ICS)
* Secondary - Use and content of the 'Tell-us Cards' actions taken by nurses as a consequence of what patients 'tell them' by means of the 'Tell-us Cards', Quality from the Patients' perspective (QPP), EQ-5D, and CQ satisfaction with communication \& care in general

Conditions

  • Communication
  • Patient Participation

Interventions

BEHAVIORAL

Tell-us Card

Patients will be invited on a daily basis, during their stay in the hospital, to state what is important for them at that moment or before discharge

Sponsors & Collaborators

  • Jeroen Bosch Ziekenhuis

    collaborator OTHER

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Ria Nijhuis-van der Sande, PhD · Radboud University Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2015-12-31
Completion
2019-05-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02401919 on ClinicalTrials.gov